PrediSurge

Founded in 2017 by its Chairman, Jean-Noel Albertini, and based in France, SAS PrediSurge, operates as a developer of digital predictive solutions for endovascular interventions that predict organ deformation and device behaviour within patient anatomy. In October 2023, PrediSurge raised EUR 6. 5 million in series A funding co-led by LIFTT and the European Innovation Council, with participation from Crédit Agricole Loire Haute-Loire, UI Investissement and Saint Victor Capital. As of 2023, the company is led by its CEO, Bruno Virieux.

PrediSurge offers a simulation platform, PlanOp™, used by medical device manufacturers and clinicians to leverage numerical simulation, specifically finite element analysis, for designing, testing, and validating medical devices with a focus on cardiovascular health. The company offers a patient-specific digital twin, which is a precise digital replica of a patient's organ, capturing both the anatomical shape and biomechanical properties. The company plans to use the October 2023 funding to expand the PlanOpTM platform.